Human genetic approaches to lower urinary tract phenotypes
降低尿路表型的人类遗传学方法
基本信息
- 批准号:10700954
- 负责人:
- 金额:$ 24.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-24 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:16S ribosomal RNA sequencing16p11.2AddressAnimal ModelBMP5 geneBenignBiological AssayChildhoodChronic Kidney FailureCohort StudiesCollaborationsComplexComputerized Medical RecordCopy Number PolymorphismDataDiagnosticDiseaseDysuriaEffectivenessElectronic Health RecordEnsureEventFunctional disorderFundingGenesGeneticGenetic DiseasesGenetic Predisposition to DiseaseGenomicsHomeostasisHuman GeneticsInvestigationLiteratureLongterm Follow-upLower urinary tractMeasurementMetabolicMorbidity - disease rateNational Human Genome Research InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesObstructionOutcomePathogenesisPathway interactionsPatientsPelvic floor structurePhenotypePopulationPtosisQuestionnairesRefluxResearchRiskRisk FactorsRoleSamplingShapesSignal TransductionSingle Nucleotide PolymorphismSymptomsTechnologyUrinary IncontinenceUrinary MicrobiomeUrinary tract infectionUrineUrologyUrotheliumVariantVesico-Ureteral RefluxVisitWNT5A geneWorkbiobankclinical careclinical diagnosisclinical phenotypecohortcomorbiditycostdiagnostic valueempowermentexomeexome sequencingexperiencefollow-upgenetic approachgenetic testinggenetic variantgenome sequencinggenome wide association studygenomic dataimprovedinsightlower urinary tract symptomsmalformationmicrobial communitymicrobial genomicsmicrobiomemicrobiotamicrobiota profilesnovelpatient subsetsphenomeprobandrare variantresponse to injurysextraiturinaryurologic
项目摘要
PROJECT 1: PROJECT SUMMARY/ABSTRACT
Genomic technologies such as exome sequencing and GWAS have not been systematically applied for most
benign urological phenotypes prior to our work at the Columbia O’Brien Urology Research Center. We have
already successfully applied genome-wide association study (GWAS) and rare copy-number variant analysis to
identify novel genes and loci associated with vesicoureteral reflux (VUR).
Here we propose to perform exome sequence of VUR patients to identify diagnostic rare single nucleotide
variants and perform an exploratory VUR whole exome association study. In collaboration with the Microbial
Genomics Biomedical Core we will conduct 16S rRNA sequencing from urine samples of a set of these patients,
with both VUR and urinary tract infections (UTI) to generate urinary microbiota profiles. We will then and analyze
microbiota profile associations with phenotypic variants and outcomes and with rare genetic variants, and
perform a microbiota-common variant genome-wide association study (mGWAS).
To extend these genomic studies to other important benign urology phenotypes we will perform a GWAS of
common lower urinary tract symptoms (LUTS) phenotypes, followed by phenome-wide association study to
uncover risk factors and comorbidities with common genetic etiology.
Our proposed studies will leverage existing data and biospecimens from four NIDDK-funded national cohorts,
the RIVUR (UTI with VUR), CUTIE (UTI without VUR), CKiD (pediatric chronic kidney disease, including reflux
VUR) and LURN (LUTS) study cohorts; as well as two large population cohorts that combine electronic medical
records and genomics, from the UK Biobank and the NHGRI-funded eMERGE network. The proposed studies
will provide new insight into the pathogenesis of disorders of high relevance to benign urology and also facilitate
introduction of genetic testing into the practice of Urology.
项目1:项目摘要/摘要
大多数基因组技术(例如外显子组测序和GWAS)尚未系统地应用
在我们在哥伦比亚奥布莱恩泌尿外科研究中心工作之前的良性泌尿外科表型。我们有
已经成功应用全基因组关联研究(GWAS)和罕见的拷贝数变体分析
识别与囊层反射X(VUR)相关的新型基因和位置。
在这里,我们建议执行VUR患者的外显子体序列以鉴定诊断稀有的单核苷酸
变体并进行探索性vur整个外显着联想研究。与微生物合作
基因组生物医学核心我们将从这些患者的尿液样本中进行16S rRNA测序,
与VUR和尿路感染(UTI)一起产生尿菌群谱。然后我们将分析
与表型变异和结果以及稀有遗传变异的微生物群谱相关,以及
执行微生物群变体基因组结合研究(MGWAS)。
为了将这些基因组研究扩展到其他重要的泌尿科表型,我们将执行
常见的较低尿路症状(LUTS)表型,然后进行全球范围的关联研究
发现具有常见遗传病因的危险因素和合并症。
我们拟议的研究将利用来自四个NIDDK资助的国家人群的现有数据和生物测量,
Rivur(带有VUR的UTI),可爱(无VUR的UTI),CKID(小儿慢性肾脏疾病,包括反流
VUR)和Lurn(LUTS)研究队列;以及两个结合电子医疗的大量人群
来自英国生物银行和NHGRI资助的Emerge Network的记录和基因组学。提出的研究
将提供有关与良性泌尿科高相关性疾病的发病机理的新见解,并促进
将基因检测引入泌尿外科实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALI G GHARAVI其他文献
ALI G GHARAVI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALI G GHARAVI', 18)}}的其他基金
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO
哥伦比亚/康奈尔/哈莱姆医院精准医学计划 HPO
- 批准号:
9525197 - 财政年份:2016
- 资助金额:
$ 24.21万 - 项目类别:
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO
哥伦比亚/康奈尔/哈莱姆医院精准医学计划 HPO
- 批准号:
9228787 - 财政年份:2016
- 资助金额:
$ 24.21万 - 项目类别:
Columbia GENIE (GENomic Integration with Ehr)
Columbia GENIE(基因组与 Ehr 集成)
- 批准号:
9134799 - 财政年份:2015
- 资助金额:
$ 24.21万 - 项目类别:
Columbia GENIE (GENomic Integration with Ehr)
Columbia GENIE(基因组与 Ehr 集成)
- 批准号:
9896294 - 财政年份:2015
- 资助金额:
$ 24.21万 - 项目类别:
Columbia GENIE (GENomic Integration with Ehr)
Columbia GENIE(基因组与 Ehr 集成)
- 批准号:
8968053 - 财政年份:2015
- 资助金额:
$ 24.21万 - 项目类别:
The Host Genome and the Urinary Microbiome in UTI and GU Structural Defects
UTI 和 GU 结构缺陷中的宿主基因组和泌尿微生物组
- 批准号:
10022308 - 财政年份:2014
- 资助金额:
$ 24.21万 - 项目类别:
Human genetic approaches to lower urinary tract phenotypes
降低尿路表型的人类遗传学方法
- 批准号:
10297545 - 财政年份:2014
- 资助金额:
$ 24.21万 - 项目类别:
Human genetic approaches to lower urinary tract phenotypes
降低尿路表型的人类遗传学方法
- 批准号:
10487492 - 财政年份:2014
- 资助金额:
$ 24.21万 - 项目类别:
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
哥伦比亚 PCC for CureGN:治愈肾小球肾病网络
- 批准号:
10212101 - 财政年份:2013
- 资助金额:
$ 24.21万 - 项目类别:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
推进原发性肾小球疾病 (UM1) 的临床研究
- 批准号:
8924174 - 财政年份:2013
- 资助金额:
$ 24.21万 - 项目类别:
相似国自然基金
PRRT2基因对16p11.2微缺失综合征表型异质性的贡献及机制研究
- 批准号:82302091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
调控CD47/SIRPα信号通路改善16p11.2缺失小鼠的突触功能和社交行为缺陷
- 批准号:82301730
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人卵母细胞始发性16p11.2拷贝数变异产生机制的研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
人卵母细胞始发性16p11.2拷贝数变异产生机制的研究
- 批准号:82271683
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
低频/罕见遗传变异调控16p11.2微缺失的先天性心脏病表型异质性的机制研究
- 批准号:82001564
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the molecular impact of 16p11.2 deletion on reward response in striatal dopamine receptor D1-expressing neurons
定义 16p11.2 缺失对纹状体多巴胺受体 D1 表达神经元奖赏反应的分子影响
- 批准号:
10750328 - 财政年份:2023
- 资助金额:
$ 24.21万 - 项目类别:
Effects of 16p11.2 copy number variation on neuronal development and pathology
16p11.2 拷贝数变异对神经元发育和病理学的影响
- 批准号:
10659523 - 财政年份:2023
- 资助金额:
$ 24.21万 - 项目类别:
GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD
GEARs 结合基因组学和环境科学的进步,加速 ASD 的可操作研究和实践
- 批准号:
10698145 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别:
Examination of gut-microbiome-brain interactions in a novel gene x environment model of neurodevelopmental disorders
在神经发育障碍的新型基因 x 环境模型中检查肠道-微生物组-大脑相互作用
- 批准号:
10730191 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别:
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
自闭症的前瞻性遗传风险评估(PROGRESS)
- 批准号:
10531728 - 财政年份:2022
- 资助金额:
$ 24.21万 - 项目类别: